Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001551163-13-000052
Filing Date
2013-05-31
Accepted
2013-05-31 09:10:21
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 restated_dec1110kprotectvedg.htm 10-K/A 818833
2 restated_dec1110kprotectv002.gif GRAPHIC 16203
3 exhibit311.htm EX-31 5660
4 exhibit312.htm EX-31 5697
5 exhibit321.htm EX-32 4082
6 exhibit322.htm EX-32 4328
  Complete submission text file 0001551163-13-000052.txt   2101174

Data Files

Seq Description Document Type Size
7 prtt-20111231.xml EX-101.INS 195177
8 prtt-20111231.xsd EX-101.SCH 15957
9 prtt-20111231_cal.xml EX-101.CAL 14565
10 prtt-20111231_def.xml EX-101.DEF 22626
11 prtt-20111231_lab.xml EX-101.LAB 82551
12 prtt-20111231_pre.xml EX-101.PRE 70518
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

EIN.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-54001 | Film No.: 13883597
SIC: 2834 Pharmaceutical Preparations